R. Sandhir et Kd. Gill, EFFECT OF LEAD ON THE BIOLOGICAL-ACTIVITY OF CALMODULIN IN RAT-BRAIN, Experimental and molecular pathology, 61(1), 1994, pp. 69-75
In the present investigation, we observed that lead in vitro activates
calmodulin at lower concentrations, and the maximum activation was ob
served at 30 mu M concentration. In vivo lead exposure (50 mg/kg body
weight, intragastrically) for a period of 8 weeks also stimulated the
activity of calmodulin by 45%. The addition of trifluoperazine resulte
d in partially inhibiting the lead-stimulated calmodulin activity, whe
reas the calcium-stimulated calmodulin activity was completely inhibit
ed by trifluoperazine. Studies with purified calmodulin from the brain
of control and lead-treated animals indicate that approximately 4 mol
e of calcium was present bound/mole of calmodulin in control animals a
nd this fraction was reduced in lead-treated animals to approximately
3 mole of calcium/mole of calmodulin. Lead distribution revealed that
approximately 68% of the total lead present was bound to calmodulin an
d the remaining 32% present was bound to non-calmodulin binding sites
following lead exposure. These results indicate that in vivo lead expo
sure is able to displace and mimic the action of calcium and this may
constitute a molecular mechanism of lead neurotoxicity. (C) 1994 Acade
mic Press, Inc.